BioSpace News Archive

NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response, today announced the closing of its previously announced upsized initial public offering of 7,441,650 shares of its common stock at a price to the public of $17.00 per share

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced that it approved equity awards for 7 new employees with a grant date of February 16, 2021 pursuant to Myovant’s 2020 Inducement Plan.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Health Canada has approved Dojolvi™ (triheptanoin) as a source of calories and fatty acids for the treatment of adult and pediatric patients with long-chain fatty acid oxidation disorders (LC-FAOD).

The Israeli Medical Center for Alzheimer’s will evaluate the safety, tolerability and efficacy of SCI-110 in patients with Alzheimer’s disease and agitation

Future corporate strategy targets large-scale cellular manufacturing needs for upcoming cell and gene therapies

AptarGroup, Inc., a global leader in drug delivery, consumer product dispensing and active packaging solutions, has partnered with CARE®, a 501 organization who works around the globe to save lives, defeat poverty and achieve social justice.

Headlands Research, a global next-generation clinical research site organization, announced that it has acquired Artemis Institute for Clinical Research.

Global health services company, Cigna Corporation (NYSE:CI), will host its virtual Investor Day on Monday, March 8, 2021 .

Founders take virtual stage at SCBIO life sciences conference to introduce revolutionary ability for early detection of cancer mutations

Elligo Health Research is proud to welcome Vice President, Healthcare Partnerships Katie Eyestone, Chief People Officer Kathleen Fairall, and Vice President, Practice Success Vanessa Watson to its leadership team.